On April 15, 2024, Sung Lee, Executive Vice President And Chief Financial Officer Of Vir Biotechnology Informed The Company That He Will Be Stepping Down From His Role, Effective May 3, 2024, To Pursue Another Career Opportunity; Co Has Initiated A Search For His Successor
Author: Benzinga Newsdesk | April 18, 2024 08:49am
On April 15, 2024, Sung Lee, Executive Vice President and Chief Financial Officer of Vir Biotechnology, Inc. (the "Company"), informed the Company that he will be stepping down from his role, effective May 3, 2024, to pursue another career opportunity. The Company has initiated a search for his successor. Mr. Lee's resignation was not because of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Posted In: VIR